The CCTS will advance new research paradigms, both within the institution and across a network of external constituents. In doing so, it will engage diverse basic science, clinical, community, industry partners and will involve increasingly diverse and expanded numbers of research participants. This transformation carries with it distinct regulatory, organizational, and cultural challenges. Thus, UK’s initiative to advance clinical research methods and approaches and to engage new partners mandates an integrated regulatory support and research integrity infrastructure that will enable this ongoing research transformation while ensuring the protection of research |
|